---
title: "DaVita Inc. (DVA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DVA.US.md"
symbol: "DVA.US"
name: "DaVita Inc."
industry: "Health Care Services"
datetime: "2026-05-20T16:07:27.399Z"
locales:
  - [en](https://longbridge.com/en/quote/DVA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DVA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DVA.US.md)
---

# DaVita Inc. (DVA.US)

## Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [www.davita.com](https://www.davita.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.55)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 31 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.68% |  |
| Net Profit YoY | -9.10% |  |
| P/B Ratio | -17.21 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12999948000.00 |  |
| Revenue | 13835088000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -147.94% | E |
| Profit Margin | 5.65% | B |
| Gross Margin | 31.42% | C |
| Revenue YoY | 6.68% | C |
| Net Profit YoY | -9.10% | D |
| Total Assets YoY | 2.22% | C |
| Net Assets YoY | -36.86% | E |
| Cash Flow Margin | 259.44% | A |
| OCF YoY | 6.68% | C |
| Turnover | 0.80 | B |
| Gearing Ratio | 94.01% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - DaVita Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "6.68%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-9.10%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-17.21",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12999948000.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "13835088000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-147.94%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "5.65%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "31.42%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "6.68%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-9.10%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.22%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-36.86%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "259.44%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "6.68%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.80",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "94.01%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 16.64 | 10/87 | 13.40 | 11.93 | 10.89 |
| PB | -17.21 | 66/87 | - | - | - |
| PS (TTM) | 0.94 | 26/87 | 0.80 | 0.73 | 0.64 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T04:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 25% |
| Hold | 4 | 50% |
| Underweight | 2 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 198.14 |
| Highest Target | 190.00 |
| Lowest Target | 126.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/DVA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/DVA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/DVA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/DVA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**